Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per-Uno Malmstrom

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Opinion in Urology|August 15, 2006
Urinary bladder cancer: hard times for evidenced-based dataPer-Uno Malmstrom
Scandinavian Journal of Urology and Nephrology. Supplementum|December 5, 2008
Bladder cancer: pathogenesisRodolfo Montironi, Per-Uno Malmstrom
European Urology Oncology|June 27, 2019
Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options?Morgan Rouprêt, Per-Uno Malmstrom, Peter Black
European Urology Oncology|July 21, 2019
How to Treat Multifocal Ta High-grade Disease if Bacillus Calmette-Guérin Is UnavailableJohannes Alfred Witjes, Maurizio Brausi, Per-Uno Malmstrom
The Canadian Journal of Urology|August 23, 2011
An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancerNazila Yavari, Stefan Andersson-Engels, Ulrika Segersten, et al.
European Urology|December 9, 2009
The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancerPaolo Gontero, Andreas Bohle, Per-Uno Malmstrom, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|December 5, 2008
Chairmen's summaryLennart Andersson, Michael J Droller, Jan Adolfsson, et al.
Oncotarget|December 17, 2017
Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patientsOwen T M Chan, Hideki Furuya, Ian Pagano, et al.
BMJ Open|January 5, 2023
Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0Christel Häggström, Oskar Hagberg, Truls Gårdmark, et al.
Plos One|May 31, 2024
Correction: Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterationsIliana K Kerzeli, Martin Lord, Milena Doroszko, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Opinion in Urology|August 15, 2006
Urinary bladder cancer: hard times for evidenced-based dataPer-Uno Malmstrom
Scandinavian Journal of Urology and Nephrology. Supplementum|December 5, 2008
Bladder cancer: pathogenesisRodolfo Montironi, Per-Uno Malmstrom
European Urology Oncology|June 27, 2019
Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options?Morgan Rouprêt, Per-Uno Malmstrom, Peter Black
European Urology Oncology|July 21, 2019
How to Treat Multifocal Ta High-grade Disease if Bacillus Calmette-Guérin Is UnavailableJohannes Alfred Witjes, Maurizio Brausi, Per-Uno Malmstrom
The Canadian Journal of Urology|August 23, 2011
An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancerNazila Yavari, Stefan Andersson-Engels, Ulrika Segersten, et al.
European Urology|December 9, 2009
The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancerPaolo Gontero, Andreas Bohle, Per-Uno Malmstrom, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|December 5, 2008
Chairmen's summaryLennart Andersson, Michael J Droller, Jan Adolfsson, et al.
Oncotarget|December 17, 2017
Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patientsOwen T M Chan, Hideki Furuya, Ian Pagano, et al.
BMJ Open|January 5, 2023
Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0Christel Häggström, Oskar Hagberg, Truls Gårdmark, et al.
Plos One|May 31, 2024
Correction: Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterationsIliana K Kerzeli, Martin Lord, Milena Doroszko, et al.
Pageof 2